New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2014
08:01 EDTDEPODepomed price target raised to $18 from $11 at JMP Securities
JMP Securities increased its price target on Depomed after the company provided 2014 guidance that the firm views as strong. The firm reiterates an Outperform rating on the stock.
News For DEPO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2016
10:01 EDTDEPOOn The Fly: Analyst Initiation Summary
Today's noteworthy imitations include: ANSYS (ANSS) initiated with an Overweight at Mitsubishi UFJ... Antero Midstream (AM) initiated with a Buy at Janney Capital... Autodesk (ADSK) initiated with a Neutral at Mitsubishi UFJ... Cheesecake Factory (CAKE) initiated with a Buy at Maxim... Depomed (DEPO) initiated with a Buy at UBS... Fleetmatics (FLTX) initiated with a Market Perform at Avondale... Glaukos (GKOS) initiated with an Overweight at Piper Jaffray... La Jolla (LJPC) initiated with an Outperform at Cowen... Manhattan Associates (MANH) initiated with a Market Perform at Avondale... Metabolix (MBLX) initiated with a Buy at Rodman & Renshaw... Opower (OPWR) initiated with an Outperform at Avondale... Social Reality (SCRI) initiated with a Buy at Rodman & Renshaw... Splunk (SPLK) initiated with an Overweight at Mitsubishi UFJ... Sucampo (SCMP) initiated with a Buy at UBS... Ultragenyx (RARE) initiated with a Buy at H.C. Wainwright... Workday (WDAY) initiated with an Overweight at Mitsubishi UFJ.
05:40 EDTDEPODepomed initiated with a Buy at UBS
Subscribe for More Information
February 8, 2016
10:22 EDTDEPOOak Ridge reports 5.04% passive stake in Depomed
10:00 EDTDEPOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:03 EDTDEPODepomed announces favorable Markman ruling in Nucynta, Nucynta ER litigation
Subscribe for More Information
06:34 EDTDEPODepomed initiated with an Overweight at Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use